Kasugamycin, monohydrochloride; (2R,3S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-4-{[(Z)-amino(carboxy)methylidene]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside hydrochloride (1:1);

[5-amino-2-methyl-6-(2,3,4,5,6-pentahydroxycyclohexyloxy)tetrahydropyran-3-yl]amino-a-iminoacetic acid hydrochloride hydrate

C₁₄H₂₅N₃O₉

Formar Colourless needle crystals.

Punto de fusion 202-204℃(decomp.).

Densidad 0.43 g/cm³ (25℃).

Solubilidad en water 228 g/l (pH 7, 25℃). en methanol 2.76, acetone, xylene <1 (all en mg/kg, 25℃).

Agudo agudo oral LD50 para male rats >5000 mg/kg.

Piel y ojos agudos percutaneous LD50 para rabbits >2000 mg/kg. Non-irritating to eyes and skin (rabbits).

Inhalación LC50 (4 h) para rats >2.4 mg/l.

Control of fungal and bacterial diseases affecting rice, vegetables and fruit.Also used to control plant diseases in various crops.

Descripción: Buff loose powder,there should be no agglomeration;

Contenido de ingrediente activo (w/w): ≥55%;

Rango de pH: 3.0~6.0;

Agua Insoluble Material (w/w): ≤2.0%;

Pérdida por secado (w/w): ≤5.0%